| 1. | | Recruiting | Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; childhood diffuse large cell lymphoma; childhood large cell lymphoma |
| 2. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ... |
| 3. | | Recruiting | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
| 4. | | Recruiting | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
| 5. | | Recruiting | Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 6. | | Recruiting | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 7. | | Recruiting | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Older Patients With Previously Untreated Non-Hodgkin's Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 8. | | Recruiting | Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Conditions: noncontiguous stage II adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma |
| 9. | | Not yet recruiting | Comparative Trial between Bexxar and Zevalin
Conditions: Follicular Lymphoma; Diffuse Large Cell Lymphoma |
| 10. | | Recruiting | Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma |
| 11. | | Recruiting | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; grade 3 follicular lymphoma |
| 12. | | Recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
| 13. | | Recruiting | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin’s Lymphoma
Conditions: adult diffuse large cell lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; grade 3 follicular lymphoma |
| 14. | | Recruiting | Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; Mantle Cell Lymphoma; Neutropenia |
| 15. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 16. | | Recruiting | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma |
| 17. | | Not yet recruiting | Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage II adult diffuse large cell lymphoma |
| 18. | | Recruiting | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma |
| 19. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; recurrent adult diffuse large cell lymphoma; recurrent adult Hodgkin's lymphoma |
| 20. | | Recruiting | Comparison of Two Induction Combination Chemotherapy Regimens Followed By High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With or Without Rituximab as Maintenance Therapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: recurrent adult diffuse large cell lymphoma |
| 21. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
| 22. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma |
| 23. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
| 24. | | Recruiting | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Conditions: recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 25. | | Recruiting | Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
Condition: recurrent adult diffuse large cell lymphoma |
| 26. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
| 27. | | Recruiting | MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ... |
| 28. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 29. | | Recruiting | Bortezomib With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent grade 3 follicular lymphoma |
| 30. | | Recruiting | LY317615 in Treating Patients With Relapsed or Refractory Lymphoma
Condition: recurrent adult diffuse large cell lymphoma |
| 31. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
| 32. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma |
| 33. | | Recruiting | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
| 34. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse small cleaved cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 35. | | Recruiting | Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
| 36. | | Recruiting | Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
Conditions: adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm |
| 37. | | Recruiting | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Conditions: adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia |
| 38. | | Recruiting | Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 39. | | Recruiting | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
| 40. | | Recruiting | Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm |
| 41. | | Recruiting | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma |
| 42. | | Recruiting | Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Condition: adult non-Hodgkin's lymphoma |
| 43. | | Recruiting | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Condition: adult non-Hodgkin's lymphoma |
| 44. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma |
| 45. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 46. | | Recruiting | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus
Conditions: Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ... |
| 47. | | Recruiting | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 48. | | Recruiting | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 49. | | Recruiting | Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Cancer; Infection |
| 50. | | Recruiting | Fluconazole Compared With Voriconazole in Preventing Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Transplantation
Conditions: childhood non-Hodgkin's lymphoma; Infection; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
